C12N2770/32011 - CPC Classification

ssRNA viruses positive-sense; Details Picornaviridae

• C12N2770/32021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 21
• C12N2770/32022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 41
• C12N2770/32023 » Virus like particles [VLP] 18
• C12N2770/32031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 5
• C12N2770/32032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 11
• C12N2770/32033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 11
• C12N2770/32034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 33
• C12N2770/32041 » Use of virus, viral particle or viral elements as a vector 3
• C12N2770/32051 » Methods of production or purification of viral material 11
• C12N2770/32061 » Methods of inactivation or attenuation 13
• C12N2770/32071 » Demonstrated in vivo effect 7
• C12N2770/32088 » For redistribution 0
• C12N2770/32111 » Aphthovirus, e.g. footandmouth disease virus 4
• C12N2770/32211 » Cardiovirus, e.g. encephalomyocarditis virus 1
• C12N2770/32311 » Enterovirus 16
• C12N2770/32411 » Hepatovirus, i.e. hepatitis A virus 1
• C12N2770/32511 » Parechovirus, e.g. human parechovirus 1
• C12N2770/32611 » Poliovirus 14
• C12N2770/32711 » Rhinovirus 3

Recent Application in this class: